Navigation Links
Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
Date:2/3/2009

SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that Eric Lai, Ph.D., has joined the Company as senior vice president, research and development.

"We are very pleased to add Eric's scientific expertise and leadership to our already strong senior management team," said Carl Hull, Gen-Probe's president and chief operating officer. "We believe Eric will play an integral role in helping our R&D team drive short-, medium- and long-term product sales growth for the Company."

Dr. Lai, 51, was most recently vice president, pharmacogenetics experimental project coordination and analysis, at GlaxoSmithKline (GSK). He was previously GSK's vice president for discovery and pipeline genetics. Before joining GSK in 1995, he was an assistant professor in the department of pharmacology at the University of North Carolina at Chapel Hill.

Dr. Lai earned a Ph.D. in pharmacology and microbiology from Columbia University, M. Phil. and M.A. degrees from the department of pharmacology at Columbia, and a B.S. in chemistry from the University of Waterloo in Ontario, Canada.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release relating to expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements regarding future growth and the plans and objectives of management are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. Some of these risks include, but are not limited to, the risk that we cannot retain key executives. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports. We assume no obligation and expressly disclaim any duty to update forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

    Contact:
    Michael Watts
    Senior director, investor relations and corporate communications
    858-410-8673


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
2. NewCardio Joins the Cardiac Safety Research Consortium
3. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
4. Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates
5. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
6. David Bagley Joins Histogen as President
7. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
8. Dr Stephan Rietiker Joins BioCeramic Therapeutics
9. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
10. GEN Joins Charles Darwin 2009 Celebration
11. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Aethlon Medical, Inc. (Nasdaq: AEMD ... validated the ability of the Aethlon Hemopurifier® to capture ... in immune-suppressed sepsis patients and also contribute to organ ... of the study was to validate the in ... and Herpes Simplex virus 1 (HSV1) by the Hemopurifier®. ...
(Date:2/22/2017)... Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 ... ) today announced its financial results for the ... "Our annual 2016 financial results reflect continued ... earnings exceeded $700 million," said Martine Rothblatt, Ph.D., ... financial results strengthen our ability to develop and ...
(Date:2/21/2017)... MENLO PARK, CA (PRWEB) , ... February 21, ... ... launch of the VTX-1 Liquid Biopsy System , a fully automated benchtop ... using microfluidic technology. The VTX-1 is being launched at the Molecular Medicine Tri ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... division, Treximo will pair its $200M operational capacity with its strategic internal ... management in areas affecting quality and operational management. With office locations ...
Breaking Biology Technology:
(Date:2/8/2017)... Report Highlights The global biosurgery ... billion in 2016 at a compound annual growth rate ... Includes - An overview of the global market for ... from 2015 and 2016, and projections of compound annual ... market on the basis of product type, source, application, ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
Breaking Biology News(10 mins):